View in EDS

Feasibility and safety of rapid glofitamab ramp-up.

Saved in:
Bibliographic Details
Title: Feasibility and safety of rapid glofitamab ramp-up.
Authors: Liem CH; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Lymphoma Alliance (GLA), Alliance, Germany., Wurm-Kuczera R; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Lymphoma Alliance (GLA), Alliance, Germany., Böckle D; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Lymphoma Alliance (GLA), Alliance, Germany., Neumann MA; German Lymphoma Alliance (GLA), Alliance, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany., Teichert M; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Novak U; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Klein Helmkamp M; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Shumilov E; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Münster, Germany., Malburg N; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Münster, Germany., Versteegen T; German Lymphoma Alliance (GLA), Alliance, Germany.; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany., Görke F; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University Hospital Leipzig, Leipzig, Germany., Magno G; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Medicine III, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.; German Cancer Consortium, Partner Site Munich, Ludwig-Maximilians-University Munich, Munich, Germany., Ghandili S; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Oncology, Hematology, and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Kauer J; German Lymphoma Alliance (GLA), Alliance, Germany.; Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Christofyllakis K; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg/Saar, Germany., Melchardt T; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Cancer Center, Paracelsus Medical University Salzburg, Salzburg, Austria., Dreger P; German Lymphoma Alliance (GLA), Alliance, Germany.; Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Ayuk F; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Subklewe M; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Medicine III, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.; German Cancer Consortium, Partner Site Munich, Ludwig-Maximilians-University Munich, Munich, Germany., Vučinić V; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University Hospital Leipzig, Leipzig, Germany.; Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany., Pott C; German Lymphoma Alliance (GLA), Alliance, Germany.; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany., Reinhardt HC; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; German Cancer Consortium, Partner site Essen/Düsseldorf, University Hospital Essen, Essen, Germany.; Center for Molecular Biotechnology, University Hospital Essen, Essen, Germany., Lenz G; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Münster, Germany., von Tresckow B; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; German Cancer Consortium, Partner site Essen/Düsseldorf, University Hospital Essen, Essen, Germany., Pabst T; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Borchmann P; German Lymphoma Alliance (GLA), Alliance, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany., Busse A; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Lymphoma Alliance (GLA), Alliance, Germany.; German Cancer Consortium, Partner Site Berlin, a Partnership between German Cancer Consortium and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Keller U; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Lymphoma Alliance (GLA), Alliance, Germany.; German Cancer Consortium, Partner Site Berlin, a Partnership between German Cancer Consortium and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Cluster of Excellence ImmunoPreCept, Charité-Universitätsmedizin Berlin, Berlin, Germany., Chapuy B; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. bjoern.chapuy@charite.de.; German Lymphoma Alliance (GLA), Alliance, Germany. bjoern.chapuy@charite.de.; German Cancer Consortium, Partner Site Berlin, a Partnership between German Cancer Consortium and Charité-Universitätsmedizin Berlin, Berlin, Germany. bjoern.chapuy@charite.de.
Source: Leukemia [Leukemia] 2026 Jul 01. Date of Electronic Publication: 2026 Jul 01.
Publication Type: Letter
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42386910
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Feasibility and safety of rapid glofitamab ramp-up.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Liem+CH%22">Liem CH</searchLink>; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Lymphoma Alliance (GLA), Alliance, Germany.<br /><searchLink fieldCode="AU" term="%22Wurm-Kuczera+R%22">Wurm-Kuczera R</searchLink>; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Lymphoma Alliance (GLA), Alliance, Germany.<br /><searchLink fieldCode="AU" term="%22Böckle+D%22">Böckle D</searchLink>; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Lymphoma Alliance (GLA), Alliance, Germany.<br /><searchLink fieldCode="AU" term="%22Neumann+MA%22">Neumann MA</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Teichert+M%22">Teichert M</searchLink>; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Novak+U%22">Novak U</searchLink>; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Klein+Helmkamp+M%22">Klein Helmkamp M</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Shumilov+E%22">Shumilov E</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Malburg+N%22">Malburg N</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Versteegen+T%22">Versteegen T</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Görke+F%22">Görke F</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University Hospital Leipzig, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Magno+G%22">Magno G</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Medicine III, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.; German Cancer Consortium, Partner Site Munich, Ludwig-Maximilians-University Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Ghandili+S%22">Ghandili S</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Oncology, Hematology, and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kauer+J%22">Kauer J</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Christofyllakis+K%22">Christofyllakis K</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg/Saar, Germany.<br /><searchLink fieldCode="AU" term="%22Melchardt+T%22">Melchardt T</searchLink>; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Cancer Center, Paracelsus Medical University Salzburg, Salzburg, Austria.<br /><searchLink fieldCode="AU" term="%22Dreger+P%22">Dreger P</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Ayuk+F%22">Ayuk F</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Subklewe+M%22">Subklewe M</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Medicine III, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.; German Cancer Consortium, Partner Site Munich, Ludwig-Maximilians-University Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Vučinić+V%22">Vučinić V</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University Hospital Leipzig, Leipzig, Germany.; Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Pott+C%22">Pott C</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Reinhardt+HC%22">Reinhardt HC</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; German Cancer Consortium, Partner site Essen/Düsseldorf, University Hospital Essen, Essen, Germany.; Center for Molecular Biotechnology, University Hospital Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Lenz+G%22">Lenz G</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22von+Tresckow+B%22">von Tresckow B</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; German Cancer Consortium, Partner site Essen/Düsseldorf, University Hospital Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Pabst+T%22">Pabst T</searchLink>; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Borchmann+P%22">Borchmann P</searchLink>; German Lymphoma Alliance (GLA), Alliance, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Busse+A%22">Busse A</searchLink>; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Lymphoma Alliance (GLA), Alliance, Germany.; German Cancer Consortium, Partner Site Berlin, a Partnership between German Cancer Consortium and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Keller+U%22">Keller U</searchLink>; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Lymphoma Alliance (GLA), Alliance, Germany.; German Cancer Consortium, Partner Site Berlin, a Partnership between German Cancer Consortium and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Cluster of Excellence ImmunoPreCept, Charité-Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Chapuy+B%22">Chapuy B</searchLink>; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. bjoern.chapuy@charite.de.; German Lymphoma Alliance (GLA), Alliance, Germany. bjoern.chapuy@charite.de.; German Cancer Consortium, Partner Site Berlin, a Partnership between German Cancer Consortium and Charité-Universitätsmedizin Berlin, Berlin, Germany. bjoern.chapuy@charite.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2026 Jul 01. <i>Date of Electronic Publication: </i>2026 Jul 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42386910
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41375-026-03003-3
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Feasibility and safety of rapid glofitamab ramp-up.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Liem CH
      – PersonEntity:
          Name:
            NameFull: Wurm-Kuczera R
      – PersonEntity:
          Name:
            NameFull: Böckle D
      – PersonEntity:
          Name:
            NameFull: Neumann MA
      – PersonEntity:
          Name:
            NameFull: Teichert M
      – PersonEntity:
          Name:
            NameFull: Novak U
      – PersonEntity:
          Name:
            NameFull: Klein Helmkamp M
      – PersonEntity:
          Name:
            NameFull: Shumilov E
      – PersonEntity:
          Name:
            NameFull: Malburg N
      – PersonEntity:
          Name:
            NameFull: Versteegen T
      – PersonEntity:
          Name:
            NameFull: Görke F
      – PersonEntity:
          Name:
            NameFull: Magno G
      – PersonEntity:
          Name:
            NameFull: Ghandili S
      – PersonEntity:
          Name:
            NameFull: Kauer J
      – PersonEntity:
          Name:
            NameFull: Christofyllakis K
      – PersonEntity:
          Name:
            NameFull: Melchardt T
      – PersonEntity:
          Name:
            NameFull: Dreger P
      – PersonEntity:
          Name:
            NameFull: Ayuk F
      – PersonEntity:
          Name:
            NameFull: Subklewe M
      – PersonEntity:
          Name:
            NameFull: Vučinić V
      – PersonEntity:
          Name:
            NameFull: Pott C
      – PersonEntity:
          Name:
            NameFull: Reinhardt HC
      – PersonEntity:
          Name:
            NameFull: Lenz G
      – PersonEntity:
          Name:
            NameFull: von Tresckow B
      – PersonEntity:
          Name:
            NameFull: Pabst T
      – PersonEntity:
          Name:
            NameFull: Borchmann P
      – PersonEntity:
          Name:
            NameFull: Busse A
      – PersonEntity:
          Name:
            NameFull: Keller U
      – PersonEntity:
          Name:
            NameFull: Chapuy B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5551
          Titles:
            – TitleFull: Leukemia
              Type: main
ResultId 1